Westcove Advises The Prescription Center in its Partnership with Altruix
LOS ANGELES, CA – October 29, 2025 – Westcove Partners, LLC (“Westcove”), a highly specialized investment bank, announced that it acted as the exclusive financial advisor to The Prescription Center (“TPC”) in its partnership with Altruix, a portfolio company of WindRose Health Investors (“WindRose”). The terms of the transaction were not disclosed. Westcove’s deal team included Justin Hand, Managing Director; Abe M’Bodj, Director; Bill Bolding, Vice President; Geno Catalano, Associate; Amr Baumy, Analyst; and Andrew Hartono, Analyst.
The Prescription Center includes two separate, but uniformly branded entities: a specialty pharmacy focused on behavioral health and a retail pharmacy. Together, they maintain a comprehensive portfolio of medications tailored to patients with mental health conditions, substance use disorders, and related chronic conditions. With a decades-long presence in Scranton, TPC is recognized for its exceptional service and dedication to serving the local community.
Michael Ruane II, Owner of TPC, stated, “Westcove treated this process with the same care and urgency that we’ve dedicated to our patients. Their team was accessible and relentless from start to finish, guiding us through each step and making a complex process feel manageable. I truly believe this partnership will enable The Prescription Center to expand its reach while preserving the high standard of care our patients and providers depend on. We couldn’t have asked for a better partner in this journey.”
Justin Hand, Managing Director of Westcove, commented, “It has been an honor to advise The Prescription Center through this process. TPC’s reputation for clinical expertise and community trust is unmatched, and this partnership with Altruix provides the scale and resources to expand that impact even further. We are proud to have played a role in helping them secure a partner who shares their values and vision.”
About The Prescription Center
Based in Scranton, Pennsylvania, The Prescription Center is a trusted independent community pharmacy brand that has served Northeastern Pennsylvania since 1988. Two distinct but complementary entities operate under the TPC brand: a retail pharmacy and a specialty pharmacy focused on behavioral health services. Together, these entities embody TPC’s reputation for clinical expertise, strong provider relationships, and a commitment to advancing access to care for more than 6,700 patients across the region.
About Altruix
Altruix, backed by WindRose Health Investors, is a behavioral health and specialty pharmacy that primarily serves individuals diagnosed with severe and persistent mental illness and intellectual or developmental disabilities. Altruix operates 15 pharmacies in the Mid-Atlantic region, serving patients through high-touch distribution relationships with community-based behavioral health agencies and long-term care facilities, enabling improved medication adherence and care management for complex and costly patient populations. For more information, visit www.altruix.com.
About WindRose Health Investors
WindRose Health Investors is a healthcare-focused private equity firm with over $3.0 billion in assets under management. Based in New York, the firm invests in companies improving quality and efficiency in healthcare delivery. With a portfolio spanning a wide range of healthcare services, WindRose partners with management teams to build industry-leading organizations positioned for long-term growth. For more information, visit www.windrose.com.
Westcove Partners is a premier healthcare-focused investment bank specializing in mergers and acquisitions, debt and equity financings, and other complex corporate finance transactions. The firm is dedicated to advising founder-operated businesses, tailoring its advisory services to address the unique challenges and opportunities these businesses face.
